Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
David Henault, David Stephen, Pierre-Antoine St-Hilaire, Nouredin Messaoudi, Franck Vandenbroucke-Menu, Eve Simoneau, Zhixia Rong, Marylène Plasse, Richard Létourneau, André Roy, Michel Dagenais, Réal Lapointe, Bich Nguyen, Anne-Marie Mes-Masson, G. Soucy & Simon Turcotte. (2023) Homogeneity in immune features between colorectal liver metastases better identifies patients with good prognosis compared to pathological response to preoperative chemotherapy. OncoImmunology 12:1.
Read now
Read now
Anna Berthel, Inka Zoernig, Nektarios A. Valous, Christoph Kahlert, Fee Klupp, Alexis Ulrich, Juergen Weitz, Dirk Jaeger & Niels Halama. (2017) Detailed resolution analysis reveals spatial T cell heterogeneity in the invasive margin of colorectal cancer liver metastases associated with improved survival. OncoImmunology 6:3.
Read now
Read now
Niels Halama, Anna Spille, Tina Lerchl, Karsten Brand, Esther Herpel, Stefan Welte, Sophia Keim, Bernd Lahrmann, Fee Klupp, Christoph Kahlert, Jürgen Weitz, Niels Grabe, Dirk Jaeger & Inka Zoernig. (2013) Hepatic metastases of colorectal cancer are rather homogeneous but differ from primary lesions in terms of immune cell infiltration. OncoImmunology 2:4.
Read now
Read now
Articles from other publishers (15)
Marion Thibaudin, Jean-David Fumet, Benoist Chibaudel, Jaafar Bennouna, Christophe Borg, Jerome Martin-Babau, Romain Cohen, Marianne Fonck, Julien Taieb, Emeric Limagne, Julie Blanc, Elise Ballot, Léa Hampe, Marjorie Bon, Susy Daumoine, Morgane Peroz, Hugo Mananet, Valentin Derangère, Romain Boidot, Henri-Alexandre Michaud, Caroline Laheurte, Olivier Adotevi, Aurélie Bertaut, Caroline Truntzer & François Ghiringhelli. (2023) First-line durvalumab and tremelimumab with chemotherapy in RAS-mutated metastatic colorectal cancer: a phase 1b/2 trial. Nature Medicine 29:8, pages 2087-2098.
Crossref
Crossref
Georg Martin Haag, Christoph Springfeld, Barbara Grün, Leonidas Apostolidis, Stefanie Zschäbitz, Mareike Dietrich, Anne-Katrin Berger, Tim Frederik Weber, Inka Zoernig, Marina Schaaf, Lisa Waberer, Daniel Wilhelm Müller, Salah-Eddin Al-Batran, Niels Halama & Dirk Jaeger. (2022) Pembrolizumab and maraviroc in refractory mismatch repair proficient/microsatellite-stable metastatic colorectal cancer – The PICCASSO phase I trial. European Journal of Cancer 167, pages 112-122.
Crossref
Crossref
Meggy Suarez-Carmona, Anja Williams, Jutta Schreiber, Nicolas Hohmann, Ulrike Pruefer, Jürgen Krauss, Dirk Jäger, Anna Frömming, Diana Beyer, Dirk Eulberg, Jarf Ulf Jungelius, Matthias Baumann, Aram Mangasarian & Niels Halama. (2021) Combined inhibition of CXCL12 and PD-1 in MSS colorectal and pancreatic cancer: modulation of the microenvironment and clinical effects. Journal for ImmunoTherapy of Cancer 9:10, pages e002505.
Crossref
Crossref
Shota Aoyama, Ryosuke Nakagawa, Satoshi Nemoto, Patricio Perez-Villarroel, James J Mulé & Adam William Mailloux. (2021) Checkpoint blockade accelerates a novel switch from an NKT-driven TNFα response toward a T cell driven IFN-γ response within the tumor microenvironment. Journal for ImmunoTherapy of Cancer 9:6, pages e002269.
Crossref
Crossref
Maarit Ahtiainen, Hanna Elomaa, Juha P. Väyrynen, Erkki-Ville Wirta, Teijo Kuopio, Olli Helminen, Toni T. Seppälä, Ilmo Kellokumpu & Jukka-Pekka Mecklin. (2021) Immune Contexture of MMR-Proficient Primary Colorectal Cancer and Matched Liver and Lung Metastases. Cancers 13:7, pages 1530.
Crossref
Crossref
Niels Halama & Uwe Haberkorn. (2020) The Unmet Needs of the Diagnosis, Staging, and Treatment of Gastrointestinal Tumors. Seminars in Nuclear Medicine 50:5, pages 389-398.
Crossref
Crossref
Farastuk Bozorgmehr, Adriane Hommertgen, Johannes Krisam, Felix Lasitschka, Jonas Kuon, Martin Maenz, Peter E. Huber, Laila König, Meinhard Kieser, Juergen Debus, Michael Thomas & Stefan Rieken. (2019) Fostering efficacy of anti-PD-1-treatment: Nivolumab plus radiotherapy in advanced non-small cell lung cancer - study protocol of the FORCE trial. BMC Cancer 19:1.
Crossref
Crossref
Jakob Nikolas Kather & Niels Halama. (2019) Harnessing the innate immune system and local immunological microenvironment to treat colorectal cancer. British Journal of Cancer 120:9, pages 871-882.
Crossref
Crossref
Jakob Nikolas Kather, Niels Halama & Dirk Jaeger. (2018) Genomics and emerging biomarkers for immunotherapy of colorectal cancer. Seminars in Cancer Biology 52, pages 189-197.
Crossref
Crossref
Bruno Christian Köhler, Benjamin Goeppert, Nina Waldburger, Kai Schlamp, Peter Sauer, Dirk Jäger, Karl Heinz Weiss, Stephan Macher-Göppinger, Henning Schulze-Bergkamen, Peter Schirmacher & Christoph Springfeld. (2018) An undifferentiated carcinoma at Klatskin-position with long-term complete remission after chemotherapy. Oncotarget 9:31, pages 22230-22235.
Crossref
Crossref
Niels Halama. 2018. Oncoimmunology. Oncoimmunology
621
639
.
Thomas Schweiger, Anna Sophie Berghoff, Christoph Glogner, Olaf Glueck, Orsolya Rajky, Denise Traxler, Peter Birner, Matthias Preusser, Walter Klepetko & Konrad Hoetzenecker. (2016) Tumor-infiltrating lymphocyte subsets and tertiary lymphoid structures in pulmonary metastases from colorectal cancer. Clinical & Experimental Metastasis 33:7, pages 727-739.
Crossref
Crossref
Niels Halama, Inka Zoernig, Anna Berthel, Christoph Kahlert, Fee Klupp, Meggy Suarez-Carmona, Thomas Suetterlin, Karsten Brand, Juergen Krauss, Felix Lasitschka, Tina Lerchl, Claudia Luckner-Minden, Alexis Ulrich, Moritz Koch, Juergen Weitz, Martin Schneider, Markus W. Buechler, Laurence Zitvogel, Thomas Herrmann, Axel Benner, Christina Kunz, Stephan Luecke, Christoph Springfeld, Niels Grabe, Christine S. Falk & Dirk Jaeger. (2016) Tumoral Immune Cell Exploitation in Colorectal Cancer Metastases Can Be Targeted Effectively by Anti-CCR5 Therapy in Cancer Patients. Cancer Cell 29:4, pages 587-601.
Crossref
Crossref
Jan Kubach, Mario Hubo, Christiane Amendt, Christopher Stroh & Helmut Jonuleit. (2015) IgG1 anti-epidermal growth factor receptor antibodies induce CD8-dependent antitumor activity. International Journal of Cancer 136:4, pages 821-830.
Crossref
Crossref
Anastasia Meshcheryakova, Dietmar Tamandl, Erika Bajna, Judith Stift, Martina Mittlboeck, Martin Svoboda, Denise Heiden, Stefan Stremitzer, Erika Jensen-Jarolim, Thomas Grünberger, Michael Bergmann & Diana Mechtcheriakova. (2014) B Cells and Ectopic Follicular Structures: Novel Players in Anti-Tumor Programming with Prognostic Power for Patients with Metastatic Colorectal Cancer. PLoS ONE 9:6, pages e99008.
Crossref
Crossref